Overview


According to FutureWise analysis the market for cruciate ligament diagnosis is expected to register a CAGR of 9.62% from 2023-2031.

The ligament is a tissue band that connects the bones and keeps the knee stable. These ligaments can be broadly divided into the cruciate ligament or collateral ligament. These ligaments can be further divided into four primary ones: Anterior Cruciate Ligament, Posterior Cruciate Ligament (PCL), Medial Collateral Ligament, Medial Cruciate Ligament, and Lateral Collateral ligament (LCL). The cruciate ligaments (i.e. the PCL or ACL) are cross ligaments that stabilize the joint and allow for a wide range of motion. The most common musculoskeletal injury among people is a knee injury. Anterior Cruciate Ligament injuries (ACL) are the most frequent. The best treatment for knee injuries is surgical reconstruction. Sports-related injuries are a major cause of soft tissue injuries worldwide. Athletes are more likely to injure their ACLs, resulting in complete paralysis and the impossibility for them to stretch their legs. ACL reconstruction is a type of surgery that involves the reconstruction of the ligament. It's performed in the middle of the knee using a graft. The cruciate knee ligaments are the anterior cruciate ligament(ACL) as well as the posterior cruciate ligament [PCL]. These ligaments consist of two strong, round bands that run from the head and the intercondyloid-notch of the foot. The ACL is medial and the PCL is lateral. They cross each other like the limbs in an X. They were named after their placement in the tibia. The ACL attaches to the anterior side of the intercondylar area and the PCL at the posterior side. Each has its own synovial sheath and the ACL and PCL are distinct throughout. The ACL prevents the tibia's slippage forward relative to the femur and the PCL prevents it from sliding backward. The cruciform or cruciate ligaments are pairs of ligaments that are arranged in a letter X pattern. They can be found in many joints, including the knee joint and atlantoaxial. Crossed ligaments are similar to those found in Jacob's ladder toy. They stabilize the joint and allow for a wide range of motion. Cruciate ligaments are found in the knee and corresponding stifle for quadrupedal animal species, as well as in the neck and fingers. Another structure similar to this in human anatomy is the cruciate ligament of the dens of the atlas vertebra. Also known as the "cruciform ligament of the atlas", it's a neck ligament that forms part of the atlantoaxial joint. Other factors, such as the growing number of knee replacement surgeries, rising incidences and ages of diseases such as osteoarthritis and rheumatoid, as well as increasing government assistance, continue to drive the market for cruciate ligament treatment and diagnosis. These drivers are important, but there are still some problems associated with the treatment and diagnosis of the cruciate ligament. Market growth may be impeded by the complications of treatment, a shortage of skilled or qualified physicians, and a poor healthcare system in low- and middle-income countries.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cruciate Ligament Diagnosis Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cruciate Ligament Diagnosis Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Zimmer Biomet
  • 3M
  • Smith and Nephew
  • DJO Global
  • Baurefeind AG
  • DeRoyal Industries
  • BSN Medical GmbH
  • Stryker
  • Arthrex
  • Conmed
  • Syneos Health Inc.
  • M2S (a Medstreaming Company)
  • Optum, Inc.
  • Evado Pty. Ltd.
  • Velos, LLC.
  • Cedaron

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Posterior Cruciate Ligament
  • Anterior Cruciate Ligament

By Injury Type

  • Grade I
  • Grade II
  • Grade III

By Product

  • Cemented Implants
  • Cement-less Implants
  • Partial Implants
  • Revision Implants

By Indication

  • Osteoarthritis
  • Rheumatoid Arthritis
  • Trauma
  • Others

By Diagnosis

  • Imaging
  • MRI
  • Ultrasound
  • Laparoscopy
  • Others

By Treatment

  • Surgery
    • Arthroscopy
    • Anterior Cruciate Ligament reconstruction
    • Others
  • Therapies
    • Rehabilitation
    • Physical Therapies
    • Others

By End Users

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cruciate Ligament Diagnosis Treatment Market By Type, By Injury Type, By Product, By Indication, By Diagnosis, By Treatment, By End Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cruciate Ligament Diagnosis Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cruciate Ligament Diagnosis Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cruciate Ligament Diagnosis Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cruciate Ligament Diagnosis Treatment Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Posterior Cruciate Ligament
        2. Anterior Cruciate Ligament

  • 8.   Cruciate Ligament Diagnosis Treatment Market, By Injury Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Grade I
        2. Grade II
        3. Grade III

  • 9.   Cruciate Ligament Diagnosis Treatment Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cemented Implants
        2. Cement-less Implants
        3. Partial Implants
        4. Revision Implants

  • 10.   Cruciate Ligament Diagnosis Treatment Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Osteoarthritis
        2. Rheumatoid Arthritis
        3. Trauma
        4. Others

  • 11.   Cruciate Ligament Diagnosis Treatment Market, By Dianosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Imaging
        2. MRI
        3. Ultrasound
        4. Laparoscopy
        5. Others

  • 12.   Cruciate Ligament Diagnosis Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Surgery
         1.1. Arthroscopy
         1.2. Anterior Cruciate Ligament reconstruction
         1.3. Others
        2. Therapies
         2.1. Rehabilitation
         2.2. Physical Therapies
         2.3. Others

  • 13.   Cruciate Ligament Diagnosis Treatment Market, By End Users Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Orthopedic Clinics
        3. Ambulatory Surgical centers
        4. Others

  • 14.   North America Cruciate Ligament Diagnosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 15.   Latin America Cruciate Ligament Diagnosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 16.   Europe Cruciate Ligament Diagnosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 17.   Asia Pacific Cruciate Ligament Diagnosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 18.   Middle East and Africa Cruciate Ligament Diagnosis Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 19.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 20.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Zimmer Biomet
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. 3M
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Smith and Nephew
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. DJO Global
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Baurefeind AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. DeRoyal Industries
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. BSN Medical GmbH
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Stryker
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Arthrex
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Conmed
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Syneos Health Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
          12. M2S (a Medstreaming Company)
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Optum, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Evado Pty. Ltd.
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Velos, LLC.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Cedaron
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 21.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 22.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients